Anterix Inc. (NASDAQ:ATEX) Chief Financial Officer Elena Marquez executed a significant divestiture of company equity on June 17, 2026, according to a recent SEC Form 4 filing. The transaction involved the disposition of 4,291 shares of Anterix common stock, generating proceeds of $341,134. Each share was sold at a price of $79.50. This sale occurred against a backdrop of substantial price appreciation for the company's equity, which has surged 266% over the past six months. At the time of the filing, Anterix shares were trading near their 52-week high of $88.12. Market analysis from InvestingPro suggests that the stock's current pricing appears overvalued relative to its Fair Value estimate, a metric that may warrant close attention from investors monitoring valuation metrics.
Before executing the sale, Ms. Marquez engaged in a separate transaction involving the acquisition of Anterix common stock through the exercise of stock options. She acquired 1,226 shares at an exercise price of $40.00 per share, totaling $49,040. These options are subject to a vesting schedule that begins on October 4, 2025, with shares becoming exercisable in three equal annual installments. Following these combined transactions, Ms. Marquez directly holds 18,387 shares of Anterix common stock.
In a separate development, Anterix Inc. announced its fiscal fourth-quarter 2026 earnings results, which surpassed Wall Street expectations. The company reported earnings of $0.98 per share, significantly outperforming the anticipated loss of $0.54 per share. Revenue for the quarter reached $1.96 million, exceeding the estimated $1.47 million. These results were bolstered by spectrum monetization, improved cash collection, and early success in new product offerings. Analysts have noted these developments positively, with several firms highlighting the company's strong financial performance. The earnings report reflects Anterix's effective strategies and operational improvements. Investors may find these results encouraging as the company continues to build on its recent successes. The positive earnings and revenue figures have drawn attention from various analyst firms, emphasizing the company's potential for future growth.
Anterix follows a strategy that includes reviewing strategies and analyzing ATEX. The company is included in AI-picked strategies, which evaluate ATEX alongside thousands of other companies every month using 100+ financial metrics. Using powerful AI to generate exciting stock ideas, it looks beyond popularity to assess fundamentals, momentum, and valuation. The AI has no bias—it simply identifies which stocks offer the best risk-reward based on current data with notable past winners that include Super Micro Computer (+185%) and AppLovin (+157%).
For investors seeking deeper insights into Anterix's valuation and performance, InvestingPro offers 12 additional ProTips and comprehensive Pro Research Reports covering over 1,400 US equities. Should you invest $2,000 in ATEX right now? ProPicks AI evaluates ATEX alongside thousands of other companies every month using 100+ financial metrics. Using powerful AI to generate exciting stock ideas, it looks beyond popularity to assess fundamentals, momentum, and valuation. The AI has no bias—it simply identifies which stocks offer the best risk-reward based on current data with notable past winners that include Super Micro Computer (+185%) and AppLovin (+157%). Want to know if ATEX is currently featured in any ProPicks AI strategies, or if there are better opportunities in the same space? See More Stocks